A Benchmark for Preservation of Normal Pituitary Function After Endoscopic Transsphenoidal Surgery for Pituitary Macroadenomas

被引:42
|
作者
Laws, Edward R., Jr. [1 ]
Iuliano, Sherry L. [1 ]
Cote, David J. [1 ]
Woodmansee, Whitney [2 ]
Hsu, Liangge [3 ]
Cho, Charles H. [3 ]
机构
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Div Endocrionol Diabet & Hypertens, Boston, MA USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Div Neuroradiol, Boston, MA USA
关键词
Endoscopic transsphenoidal surgery; Macroadenoma; Pituitary function; Pituitary surgery; DELAYED HYPONATREMIA; ENDOCRINE FUNCTION; ADENOMAS; ENDONASAL; RECOVERY; COMPLICATIONS; RESECTION; HYPOPITUITARISM; PREDICTORS; PRESSURE;
D O I
10.1016/j.wneu.2016.04.059
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
INTRODUCTION: We report a contemporary consecutive series of 80 patients operated on for benign pituitary macroadenomas, followed endocrinologically for at least 3 months postoperatively. These patients were systematically evaluated preoperatively by high-resolution magnetic resonance imaging designed to detect the position of normal gland relative to the lesion. The rate of preservation of normal pituitary was critically analyzed using this strategy combined with endoscopic transsphenoidal resection. METHODS: This is a retrospective review of 46 women and 34 men with mean postoperative follow-up of 14 months (range, 3-30 months). The lesions encountered consisted of 80 pituitary macroadenomas (55 nonfunctioning, 18 acromegaly, 5 prolactinoma, 1 Cushing, one thyroid-stimulating hormone). Pituitary endocrine status was determined preoperatively and at most recent follow-up, and categorized as normal or impaired, based on laboratory studies showing new hormone deficiency or the need for pituitary hormone replacement therapy. RESULTS: Fifty-three patients (66.3%) had normal endocrine function preoperatively; 3 (5.7%) had loss of function postoperatively (1 transient). Twenty-seven patients (33.8%) had impaired function preoperatively; postoperatively 20 (74.1%) were unchanged, and 5 (18.5%) were worse; 2 (7.4%) recovered lost pituitary function. Of 80 patients undergoing resection, 5 (6.3%) had worsened pituitary function postoperatively. Patients with recurrent lesions (n = 5, 6.3%) and those presenting with pituitary tumor apoplexy (n = 5, 6.3%) were more likely to become further impaired. Other endocrine sequelae included 2 patients with permanent postoperative diabetes insipidus and 3 with transient symptomatic syndrome of inappropriate secretion of antidiuretic hormone. CONCLUSIONS: The preservation and restoration of hormonal function are essential to assessing the outcome of surgery and to the patient's quality of life. Careful analysis of the anatomy of the pituitary lesions and their effect on the anatomy and physiology of the pituitary gland are crucial to success and allow modern technological advances to provide fewer complications of therapy and improved outcomes for our patients. The benchmarks provided in this article are a stimulus for even better results in the future as we take advantage of technical and conceptual advances and the benefits of multidisciplinary collaboration.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 50 条
  • [41] Endoscopic transseptal transsphenoidal surgery for pituitary tumors - Comments
    Laws, ER
    Post, KD
    NEUROSURGERY, 1997, 40 (05) : 946 - 946
  • [42] Endoscopic Versus Microscopic Transsphenoidal Surgery for Pituitary Tumors
    Huang Guo-Dong
    Ji Tao
    Yang Ji-Hu
    Zheng Wen-Jian
    Zhang Xie-Jun
    Guo Jian
    Li Zhen
    Jiang Tai-Peng
    Ding Jian-Jun
    Gao Yong-Zhong
    Liu Wenlan
    Li Wei-Ping
    JOURNAL OF CRANIOFACIAL SURGERY, 2016, 27 (07) : E648 - E655
  • [43] Advanced virtual endoscopy for endoscopic transsphenoidal pituitary surgery
    Wolfsberger, Stefan
    Neubauer, Andre
    Buehler, Katia
    Wegenkittl, Rainer
    Czech, Thomas
    Gentzsch, Stephan
    Boecher-Schwarz, Hans-Gerd
    Knosp, Engelbert
    NEUROSURGERY, 2006, 59 (05) : 1001 - 1009
  • [44] New endoscope shaft for endoscopic transsphenoidal pituitary surgery
    van Lindert, EJ
    Grotenhuis, JA
    NEUROSURGERY, 2005, 57 (01) : 203 - 205
  • [45] A Learning Curve of Endoscopic Transsphenoidal Surgery for Pituitary Adenoma
    Chi, Fengling
    Wang, Yu
    Lin, Yingying
    Ge, Jianwei
    Qiu, Yongming
    Guo, Liemei
    JOURNAL OF CRANIOFACIAL SURGERY, 2013, 24 (06) : 2064 - 2067
  • [46] Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas
    Hofstetter, Christoph P.
    Shin, Benjamin J.
    Mubita, Lynn
    Huang, Clark
    Anand, Vijay K.
    Boockvar, John A.
    Schwartz, Theodore H.
    NEUROSURGICAL FOCUS, 2011, 30 (04)
  • [47] Modified transseptal approach in endoscopic transsphenoidal pituitary surgery
    Gan, R.
    Stokes, S.
    Bahl, A.
    Jose, J.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2023, 137 (12): : 1409 - 1412
  • [48] Managing complications of endoscopic transsphenoidal surgery in pituitary adenomas
    Abhinav, Kumar
    Tyler, Matthew
    Dale, Oliver T.
    Mohyeldin, Ahmed
    Fernandez-Miranda, Juan C.
    Katznelson, Laurence
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2020, 15 (05) : 311 - 319
  • [49] Subclinical hemorrhagic nonfunctionning pituitary adenoma: pituitary gland function status, endoscopic endonasal transsphenoidal surgery, and outcomes
    Wang, Ming
    Jiang, Yugang
    Cai, Yang
    Wu, Huixuan
    Peng, Yong
    BRITISH JOURNAL OF NEUROSURGERY, 2023, 37 (03) : 265 - 271
  • [50] Intraoperative MRI in transsphenoidal resection of invasive pituitary macroadenomas
    Hlavac, Michal
    Knoll, Andreas
    Etzrodt-Walter, Gwendolin
    Sommer, Fabian
    Scheithauer, Marc
    Coburger, Jan
    Wirtz, Christian Rainer
    Pala, Andrej
    NEUROSURGICAL REVIEW, 2019, 42 (03) : 737 - 743